Advancements in Radiation Therapy for Prostate Cancer

Advanced technology and novel techniques are driving the use of radiation in the treatment of prostate cancer, according to Dr. Daniel Spratt. In a recent presentation, Dr. Spratt discussed the evolution of radiotherapy in prostate cancer and highlighted ongoing research on less invasive and more accurate techniques. The use of radiation therapy has expanded, particularly in patients with ultra high-risk or node-positive prostate cancer. Advances in technology have led to improved outcomes and reduced side effects for patients. For example, the introduction of spacer gel has significantly reduced toxicity by separating the prostate from the rectum. Modern trials have shown promising results for ultra-hypofractionated radiotherapy and stereotactic body radiation therapy (SBRT) in different risk groups of prostate cancer patients. Shorter treatment regimens and the concept of dose painting are also being explored. Additionally, artificial intelligence (AI) predictive models are being used to identify patients who would benefit from the addition of androgen deprivation therapy (ADT) to radiation. These advancements in radiation therapy offer new possibilities for the treatment of prostate cancer.